Geriatric Medicines Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecasts 2016–2024

Request Brochure Request Discount

Report Code: ZMR-2557 | Report Format : | Status : Upcoming |

Abstract

Global Geriatric Medicines Market: Overview

Geriatrics is a division of medicines related to the remedial, clinical, social, and preventive aspects of ill health generally among populace over 65 years. The majority of the geriatrics is not capable to take their medication accurately at the planned time owing to complex psychological and medical issues. The geriatric population needs special attention and care for the rapid revival of disorder or disease.

Global Geriatric Medicines Market: Growth Factors

The growth of the worldwide geriatric medicines market is mainly fueled by the general increase in the aged populations in several regions, mainly in developed and developing countries. The mounting frequency of adults aged over 65 years that are distressed by a range of chronic conditions and the increasing prevalence of diseases such as cancer, neurological disorders, cardiovascular disorder, and rheumatoid arthritis are the few of major factors driving the growth of the geriatric medicines market. Moreover, a huge number of aged people dependent on polypharmacy are likely to have side-effects owing to the interactions of the diverse medicines. This, in turn, has augmented the need for geriatric care and thus boosting the geriatric medicines market growth.

Also, the rising occurrence medication-related issues among older adults and the urgent requirement for palliative care are the determining factors fueling the geriatric medicines market growth. Nevertheless, the dearth of wakefulness about the accessibility of geriatric care among aged patients in budding countries is a critical factor expected to hamper the market growth. Then again, the continuous progress in healthcare infrastructure in a number of countries in the developed and developing regions is anticipated to bring up exhilarating avenues for the market players.

Global Geriatric Medicines Market: Segmentation

The worldwide geriatric medicines market can be segmented based on therapeutic category, condition, and region. The therapeutic category of the geriatric medicines market can be bifurcated into antihypertensive, analgesic, antidiabetic, statins, anticoagulant, proton pump inhibitor, antidepressant & antipsychotic, and others. The condition segment of the geriatric medicines market can be categorized into arthritis, cardiovascular, cancer, neurological, respiratory, osteoporosis, and others. Geographically, the worldwide geriatric medicines market can be divided into North America, Europe, Latin America, Asia Pacific, and Middle East & Africa.

Global Geriatric Medicines Market: Regional Analysis

North America is anticipated to dominate the worldwide geriatric medicines market. The market growth in this region can be attributed to the existence of a huge geriatric population, a well-developed compensation scenario, and the existence of superior healthcare facilities. Further, Asia Pacific region is also expected to grow at a rapid pace owing to the noteworthy enhancements in the healthcare facilities, the launch of numerous generic and patented drugs, the increase in disposable incomes, a rise in private & public healthcare expenditure, and the rise in a number of elderly population.

Global Geriatric Medicines Market: Competitive Players

The prominent players in the worldwide geriatric medicines market include Boehringer Ingelheim GmbH, Eli Lilly and Company, Pfizer, Inc., Bristol-Myers Squibb Company, Abbott Laboratories, Inc., Merck & Company Inc., GlaxoSmithKline plc, AstraZeneca plc, Sanofi S.A., and Novartis AG.

Global Geriatric Medicines Market: Regional Segment Analysis

  • North America
    • The U.S.
  • Europe
    • The UK
    • France
    • Germany
  • The Asia Pacific
    • China
    • Japan
    • India
  • Latin America
    • Brazil
  • The Middle East and Africa

What Report Provides

  • Full in-depth analysis of the parent market
  • Important changes in market dynamics
  • Segmentation details of the market
  • Former, on-going, and projected market analysis in terms of volume and value
  • Assessment of niche industry developments
  • Market share analysis
  • Key strategies of major players
  • Emerging segments and regional markets
  • Testimonials to companies in order to fortify their foothold in the market.

Related Reports

Peptide and Anticoagulant Drugs Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2016–2024

Price : $ 3999.00 | Report Code: ZMR-3130 | Report Format:

Global Peptide and Anticoagulant Drugs Market: Overview Peptides anticoagulant drugs are likely to have a wide range of applications in treating several diseases for example osteoporosis, cancer, cardiovascular, diabetes, and coagulation disorders. Peptides are basically molecules that are univ...Read More

Crohn’s Disease Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2018–2024

Price : $ 3999.00 | Report Code: ZMR-3033 | Report Format:

Global Crohns Disease Market: Overview An inflammatory disease of bowel affecting any part of the Gastro-Intestinal Tract (GI Tract) is termed as Crohns disease. It is classified into a segment of chronic disease. Crohns disease is considered to impact nearly every part of an individuals life, a...Read More

Anti-Neoplastic Agents Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecasts, 2016–2024

Price : $ 3999.00 | Report Code: ZMR-3024 | Report Format:

Global Anti-Neoplastic Agents Market: Overview Anti-neoplastic agents are primarily used as a first-line treatment for cancer therapy as well as in combination with radiation or surgical therapy. A lot of anti-neoplastic agents are accessible commercially for the therapy of various kinds of canc...Read More

Kidney Fibrosis Treatment Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2018–2026

Price : $ 3999.00 | Report Code: ZMR-2989 | Report Format:

Global Kidney Fibrosis Treatment Market: Overview Fibrosis is the growth of extreme connective tissue owing to some injury or some disease. Disease in the kidney can cause kidney fibrosis. In this state, the kidneys fail to work properly which gradually leads to severe conditions. Kidney transpl...Read More

Oncology Based In-vivo CRO Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2016–2024

Price : $ 3999.00 | Report Code: ZMR-2982 | Report Format:

Global Oncology Based In-vivo CRO Market: Overview CRO basically stands for contract research organization which presents research services to a pharmaceutical, biotechnology, and medical devices key players on the basis of the contract. CRO offers services such as clinical research, biologic as...Read More

Download Brochure
Why Choose Us ?

24/5 Research support

Resolved your research queries from industry expert. Request for a free research sample before report purchase.

Custom research service

Ask the Analyst to customize an exclusive study to serve your research needs.

Quality & Accuracy

Zion Market Research reports offers best quality reports based on various authentic and accurate data findings.

Customer Satisfaction

We ensure that our client's all research needs are met with customized, in-depth analysis solutions.

Information security

We never share your personal and confidential information. Your personal information is safe and secure with us.